This Technical Blog was written with input from Christopher Perry, PhD & Arthur Cheng, PhD.

Content has been informed by the presentation and discussion following the recent webinar “Beyond Muscle Mass: What Murine Muscle Function Reveals”.

Direct measurements of muscle function can reveal changes in strength, fatigue resistance, contractile kinetics, recovery, and susceptibility to injury that may not be evident from muscle mass, histology, or molecular findings alone. To interpret those measurements well, the experimental preparation must fit the question the study is designed to answer.

In vivo, in situ, and in vitro assessments are complementary approaches. Each involves a trade-off: greater experimental control generally comes with less physiological context. The appropriate choice depends on which aspects of biology the study needs to preserve and which conditions it needs to control.

There is no universally best approach to muscle-function testing. An in vivo method may be well suited to tracking integrated performance over time, while an in vitro preparation may be necessary to isolate intrinsic contractile properties or a direct response to an intervention. Neither approach is inherently more informative. Each answers a different type of question.

Before selecting a preparation, define the functional outcome of interest and the level of biology the study needs to capture.

• Is the question about integrated muscle-group performance over time?
• Is it about the function of a specific muscle while retaining its nerve and blood supply?
• Is it about intrinsic muscle properties under controlled conditions of length, temperature, stimulation, or exposure?

Those distinctions should guide method selection, rather than habit, equipment availability, or a presumed hierarchy among the three approaches.

In vivo muscle-function assessment captures the response of a muscle group within an intact physiological system. Neural input, circulation, body-temperature regulation, and other systemic influences remain part of the response. This makes in vivo testing particularly useful when the research question concerns functional performance in the broader physiological setting.

In vivo testing is also well suited to longitudinal study designs. Repeated measures can help researchers follow disease progression, physiological adaptation, or response to an intervention within the same subjects over time.

That physiological integration also brings practical considerations. The protocol must be appropriate for the study model, especially when working with frail or vulnerable subjects. Stimulation approach, positioning, preparation, and confirmation of maximal activation can all affect confidence in a torque or force measurement. Appropriate anesthesia, physiological monitoring, and supportive care are essential to maintaining physiological stability throughout testing.

Pilot work in the actual study model, not only in healthy controls, helps establish what the preparation can tolerate and what values are technically achievable. This is particularly important when a protocol that is well tolerated by healthy controls may need to be shortened or otherwise adapted for a disease model.

In situ assessment evaluates an individual muscle while retaining its nerve and blood supply. This preparation can preserve important physiological context while allowing a more focused examination of a specific muscle than is possible with a whole-body performance measure.

In situ testing is useful when the question concerns the function of a selected muscle but still depends on retained innervation and circulation. It should be selected because it answers that question, not simply because it appears to sit between in vivo and in vitro testing.

As with any preparation, design choices shape interpretation. The selected muscle, stimulation protocol, experimental endpoint, and normalization strategy should all align with the biology being studied and the functional outcome that matters most.

In vitro assessment studies an isolated muscle outside the organism. It provides the greatest control over experimental conditions, including muscle length, stimulation, temperature, extracellular environment, and direct exposure to pharmacological agents.

This level of control is valuable when the question concerns intrinsic muscle properties or mechanisms that influence force generation. It can help distinguish muscle-specific changes from effects that arise through the nervous system, circulation, inflammation, or other whole-body influences.

The preparation does not retain those systemic influences, so in vitro findings must be interpreted within the limits of what an isolated muscle can represent. For many studies, that reduction in complexity is precisely the reason to select an in vitro approach.

Maximal force is an important endpoint, but it is only one part of the functional phenotype. Depending on the study question, force-frequency relationships, contractile kinetics, fatigability, and recovery may reveal changes that a peak-force measurement does not capture.

Submaximal force-frequency responses can provide insight into activation sensitivity and excitation-contraction coupling. Measures of contraction and relaxation can help characterize contractile kinetics. Fatigue and recovery protocols can identify task-dependent deficits in performance, including changes that are not apparent from maximal force alone.

The preparation and the outcome measure should be selected together. A study seeking to characterize fatigue resistance in an intact physiological setting may require a different approach from one focused on the intrinsic mechanisms contributing to reduced contractile speed.

In vivo, in situ, and in vitro assessments can be used independently or together. The sequence should follow the scientific question rather than a fixed order.

In some programs, in vivo testing establishes whether function changes over time, followed by in situ or in vitro work to explore the muscle-specific or mechanistic basis of that change. In others, a finding under controlled in vitro conditions may need to be tested in vivo to determine whether it holds within the integrated physiological system and whether broader effects alter its interpretation.

The goal is not to add measurements for their own sake. It is to match each measurement to a question the preparation is capable of answering. Interpreted alongside structural, molecular, and physiological data, functional outcomes can provide a clearer account of disease severity, adaptation, and response to intervention.